Publications by authors named "Signe Friesland"

Claim this Profile
C
Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment.
Mark Zupancic, Madeleine Birgersson, Ourania N Kostopoulou, Linda Marklund, Rusana Bark, Signe Friesland

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.
Maria Gebre-Medhin, Gabriel Adrian, Per Engström, Hedda Haugen Cange, Lalle Hammarstedt-Nordenvall, Signe Friesland

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.
Anna Liza M P de Leeuw, Frank J P Hoebers, Jordi Giralt, Yungan Tao, Chris H J Terhaard, Signe Friesland

Radiother Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validated prediction of xerostomia in a real-world population: a step toward model-guided radiotherapy.
Emmy Dalqvist, Tiziana Rancati, Anna Embring, Gabriella Alexandersson von Döbeln, Ingmar Lax, Signe Friesland

Acta Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome.
Claes Mercke, Signe Friesland, Anders Berglund, Gun Wickart Johansson, Gregori Margolin

Head Neck· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.
Anna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, Sergi Benavente, Thanh-Vân F Nguyen, Signe Friesland

Radiother Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
Anna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, Sergi Benavente, Thanh-Vân France Nguyen, Signe Friesland

Radiother Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies.
Mark Zupancic, Anders Näsman, Signe Friesland, Tina Dalianis

Anticancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report.
Mark Zupancic, Pedro Farrajota Neves da Silva, Karam Kas Elyas, Signe Friesland, Thomasine Ellingsen Cederö

Case Rep Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Signe Friesland

Radiat Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial.
Claes Mercke, Gun Wickart-Johansson, Helena Sjödin, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Signe Friesland

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Signe Friesland

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort.
Mark Zupancic, Anders Näsman, Anders Berglund, Tina Dalianis, Signe Friesland

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brachytherapy and osteoradionecrosis in patients with base of tongue cancer.
Daniel Danielsson, Eva Hagel, Sebastian Dybeck-Udd, Mats Sjöström, Göran Kjeller, Signe Friesland

Acta Otolaryngol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features.
Mark Zupancic, Stefan Holzhauser, Liquin Cheng, Torbjörn Ramqvist, Juan Du, Signe Friesland

Viruses· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study.
Helena Ullgren, Angela Camuto, Sumy Rosas, Simon Pahnke, Beatrice Ginman, Signe Friesland

Acta Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Signe Friesland

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status.
Malin Wendt, Lalle Hammarstedt-Nordenvall, Mark Zupancic, Signe Friesland, David Landin

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.
Marcus Skribek, Konstantinos Rounis, Soren Afshar, Oscar Grundberg, Signe Friesland

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer.
Maria Gebre-Medhin, Eva Brun, Per Engström, Hedda Haugen Cange, Lalle Hammarstedt-Nordenvall, Signe Friesland

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial).
Georgios Tsakonas, Lena Specht, Claus Andrup Kristensen, Maria Herlestam Calero Moreno, Hedda Haugen Cange, Signe Friesland

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study.
Eva Onjukka, Claes Mercke, Einar Björgvinsson, Anna Embring, Anders Berglund, Signe Friesland

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases.
Georgios Tsakonas, Caroline Kamali, Luigi De Petris, Signe Friesland, Rolf Lewensohn

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
Georgios Tsakonas, Rolf Lewensohn, Johan Botling, Cristian Ortiz-Villalon, Patrick Micke, Signe Friesland

Eur J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, Signe Friesland

Radiat Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis